Jacobs Levy Equity Management
GNCA

Jacobs Levy Equity Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Jacobs Levy Equity Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,260
Closed -$107K – 1059
2016
Q4 		$107K Sell
3,260
-2,852
-47% -$93.9K ﹤0.01% 903
2016
Q3 		$250K Sell
6,112
-313
-5% -$12.3K ﹤0.01% 844
2016
Q2 		$211K Sell
6,425
-4,262
-40% -$156K ﹤0.01% 999
2016
Q1 		$662K Buy
+10,687
New +$339K 0.01% 663

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Jacobs Levy Equity Management's GNCA Position: Q1 2017 in Review

Jacobs Levy Equity Management sold out of Genocea Biosciences, Inc. (GNCA) in Q1 2017, closing a stake of 3,260 shares — an estimated $107K sold.

Jacobs Levy Equity Management first reported a position in GNCA in Q1 2016 and held it in 4 quarters. The position peaked at $662K in Q1 2016. 49 funds tracked by Wall St. Rank hold GNCA as of Q1 2017.

  • Jacobs Levy Equity Management reported no remaining Genocea Biosciences, Inc. position as of Q1 2017 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 3,260 Genocea Biosciences, Inc. shares in Q1 2017, an estimated $107K.
  • Jacobs Levy Equity Management first reported a position in Genocea Biosciences, Inc. in Q1 2016 and held it in 4 quarters.
  • Jacobs Levy Equity Management's Genocea Biosciences, Inc. position peaked at $662K in Q1 2016.
  • 49 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q1 2017.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2017, filed 15 May 2017.